← Eichor
Condition: Pediatric Osteosarcoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pediatric Osteosarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumo
Phase 1/Phase 2 · 71 location(s) · Merck Sharp & Dohme LLC · NCT06395103Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory
Phase 1 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT03721068Pediatric PET/MR Image Registry
Phase N/A · 1 location(s) · Stanford University · NCT03458520A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Phase 2 · 6 location(s) · Nationwide Children's Hospital · NCT05135975A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intr
Phase 2 · 1 location(s) · Vall d'Hebron Institute of Oncology · NCT06650514Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diag
Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT07428993Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT07502885Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcoma
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT07222735Lurbinectedin in FET-Fused Tumors
Phase 1/Phase 2 · 6 location(s) · Children's Hospital of Philadelphia · NCT05918640Biomarkers of Resiliency In Childhood Cancer Surgery
Phase N/A · 1 location(s) · Mayo Clinic · NCT06674811Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/Phase 2 · 10 location(s) · St. Jude Children's Research Hospital · NCT04901702Molecular Analysis Of Solid Tumors
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT01050296Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
Phase 1 · 1 location(s) · Emory University · NCT07144254Tissue Expression of Krüppel-Like Factors 4 and 7 in Bone Tumors
Phase N/A · 2 location(s) · Ain Shams University · NCT06935864Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumor
Phase 1 · 1 location(s) · University of Wisconsin, Madison · NCT02508038SPEARHEAD-3 Pediatric Study
Phase 1/Phase 2 · 10 location(s) · USWM CT, LLC · NCT05642455Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
NA · 3 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06796543Losartan + Sunitinib in Treatment of Osteosarcoma
Phase 1 · 4 location(s) · University of Colorado, Denver · NCT03900793B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT04897321Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Phase 1 · 8 location(s) · Amgen · NCT07297979Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Phase 1/Phase 2 · 15 location(s) · Jazz Pharmaceuticals · NCT05734066Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)
Phase 1/Phase 2 · 4 location(s) · University Hospital Tuebingen · NCT06094101Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Phase 1/Phase 2 · 1 location(s) · University of Florida · NCT06625190
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.